Andres Morales La Madrid Selected Research

dipinacoline glutamate

2/2024	Brain stem tumors in children less than 3 months: Clinical and radiologic findings of a rare disease.
1/2022	Neurological Symptom Improvement After Re-Irradiation in Patients With Diffuse Intrinsic Pontine Glioma: A Retrospective Analysis of the SIOP-E-HGG/DIPG Project.
1/2022	Repurposing Vandetanib plus Everolimus for the Treatment of ACVR1-Mutant Diffuse Intrinsic Pontine Glioma.
12/2018	Tumor dissemination through surgical tracts in diffuse intrinsic pontine glioma.
5/2017	Second re-irradiation for DIPG progression, re-considering "old strategies" with new approaches.
1/2017	Tissue sampling in diffuse intrinsic pontine glioma (DIPG) at progression.
1/2017	Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group.
1/2017	Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease.
1/2015	Future Clinical Trials in DIPG: Bringing Epigenetics to the Clinic.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andres Morales La Madrid Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 02/2013
7	Diffuse Intrinsic Pontine Glioma 01/2022 - 01/2015
5	Glioma (Gliomas) 01/2020 - 01/2015
3	Brain Stem Neoplasms (Brain Stem Tumor) 02/2024 - 12/2018
3	Neuroblastoma 05/2014 - 03/2012
1	Ataxia (Dyssynergia) 01/2022
1	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 01/2021
1	Rhabdomyosarcoma 01/2021
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 03/2012

Drug/Important Bio-Agent (IBA)

9	dipinacoline glutamateIBA 02/2024 - 01/2015
2	AntibodiesIBA 01/2021 - 03/2012
1	Everolimus FDA Link 01/2022
1	vandetanib (ZD6474)IBA 01/2022
1	Procarbazine (Matulane)FDA Link 01/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	Gemcitabine FDA Link 01/2021
1	glutamate receptor delta 2IBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	tyrosine receptor (receptor, tyrosine)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Histones (Histone)IBA 01/2015
1	RNA (Ribonucleic Acid)IBA 05/2014
1	DNA (Deoxyribonucleic Acid)IBA 02/2013

Therapy/Procedure

2	Re-Irradiation 01/2022 - 01/2017
2	Drug Therapy (Chemotherapy) 01/2021 - 02/2013
2	Therapeutics 01/2020 - 05/2017
1	Chemoradiotherapy 01/2020
1	Radiotherapy 05/2017
1	Aftercare (After-Treatment) 02/2013